ArticleJournal of bone and mineral metabolism2026

24-month real-world persistence and compliance of denosumab versus alendronate among postmenopausal women with osteoporosis in Australia, Taiwan, South Korea, Hong Kong, and Singapore.

Tang Ching Lau et al.PubMed ↗Publisher ↗

No numbers read from the abstract.